| Detected | Trial | Change |
|---|---|---|
| 2026-06-11 | NCT05939414 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation… |
Trial sites expanded: 144 -> 147 locations |
| 2026-06-09 | NCT05670106 A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of… |
Trial completed |
| 2026-06-09 | NCT05670106 A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of… |
date change Completion moved earlier: 2026-06-30 -> 2026-04-22 |
| 2026-05-28 | NCT05849298 A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With… |
Trial sites reduced: 41 -> 37 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05803941 | Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate… | Prostate Cancer | Recruiting |
| Phase 3 | |||
| NCT05939414 | An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation… | Oligometastatic Prostate Cancer (OMPC) | Recruiting |
| Phase 2 | |||
| NCT06866938 | Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance… | Metastatic Castration-resistant Prostate Cancer | Recruiting |
| NCT06004661 | Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and… | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Recruiting |
| NCT05658003 | A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy… | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Active, Not Recruiting |
| NCT06894511 | An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination… | Metastatic Castration Resistant Prostate Cancer (mCRPC) | Active, Not Recruiting |
| NCT05849298 | A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With… | Prostatic Neoplasm | Active, Not Recruiting |
| NCT07047118 | A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in… | Prostatic Cancer, Castration-Resistant | Active, Not Recruiting |
| Phase 1 | |||
| NCT06531499 | A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu)… | Metastatic Castration-Resistant Prostate Cancer | Recruiting |
| NCT06379217 | NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted… | Metastatic Neuroendocrine Prostate Cancer | Active, Not Recruiting |